Vertex (VRTX) PT Raised to $341 at Truist Securities, Following Clinical Business Update
Tweet Send to a Friend
Truist Securities analyst Robyn Karnauskas raised the price target on Vertex (NASDAQ: VRTX) to $341.00 (from $331.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
